DPPIV

DPPIV 분자 정보

영어 이름Dipeptidyl peptidase IV시판 약물 수42
임상 약물 수37표적 별명Dipeptidyl peptidase IV membrane form,T-cell activation antigen CD26,Adenosine deaminase complexing protein 2,Dipeptidyl peptidase IV,Dipeptidyl peptidase IV soluble form,ADCP2,Dipeptidyl peptidase 4,ADCP-2,ADABP,DPP4,Dipeptidylpeptidase IV (CD26, Adenosine Deaminase Complexing Protein 2),DPP IV,TP103,CD26,Dipeptidyl-Peptidase 4,Dipeptidylpeptidase 4,CD26 Antigen,DPPIV,Xaa-Pro-Dipeptidylaminopeptidase,Gly-Pro Naphthylamidase,Post-Proline Dipeptidyl Aminopeptidase IV
최고 연구 개발 단계Approved
영어 이름Dipeptidyl peptidase IV
표적 별명Dipeptidyl peptidase IV membrane form,T-cell activation antigen CD26,Adenosine deaminase complexing protein 2,Dipeptidyl peptidase IV,Dipeptidyl peptidase IV soluble form,ADCP2,Dipeptidyl peptidase 4,ADCP-2,ADABP,DPP4,Dipeptidylpeptidase IV (CD26, Adenosine Deaminase Complexing Protein 2),DPP IV,TP103,CD26,Dipeptidyl-Peptidase 4,Dipeptidylpeptidase 4,CD26 Antigen,DPPIV,Xaa-Pro-Dipeptidylaminopeptidase,Gly-Pro Naphthylamidase,Post-Proline Dipeptidyl Aminopeptidase IV
시판 약물 수42
임상 약물 수37
최고 연구 개발 단계Approved

DPPIV분자 배경

Dipeptidyl peptidase-IV (DPPIV) is also known as adenosine deaminase complexing protein 2, DPPIV or CD26 is antigenic enzyme expressed on the surface of most cell types and is associated with immune regulation, signal transduction and apoptosis. It is an intrinsic membrane glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the N-terminus of polypeptides. The substrates of DPPIV are proline (or alanine)-containing peptides and include growth factors, chemokines, neuropeptides, and vasoactive peptides. DPPIV plays a major role in glucose metabolism. It is responsible for the degradation of incretins such as GLP-1. DPPIV plays an important role in tumor biology, and is useful as a marker for various cancers, with its levels either on the cell surface or in the serum increased in some neoplasms and decreased in others. DPPIV also binds the enzyme adenosine deaminase specifically and with high affinity. The significance of this interaction has yet to be established.

DPPIV분자 별명

DPP4,ADABP,ADCP2,CD26,DPPIV,TP103

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Dutogliptin TartrateREC-01; PHX-1149; PHX-1149TPhase 3 ClinicalPhenomixDiabetes Mellitus, Type 2; Leukemia, Myeloid, Acute; Myocardial Infarction; Renal Insufficiency; ST Elevation Myocardial Infarction
상세
YogliptinPhase 3 ClinicalChengdu Easton Biopharmaceuticals Co Ltd, Sichuan Sunheal Pharmaceutical Co LtdDiabetes Mellitus, Type 2
상세
Empagliflozin/Sitagliptin HydrochlorideDW1026C1; DW-1026C1; DW1026C2; DW-1026C2Phase 3 ClinicalDaewon Pharmaceutical Co LtdDiabetes Mellitus, Type 2
상세
Dapagliflozin formate/LinagliptinIN-C009; AJU-A51Phase 3 ClinicalAju Pharm Co Ltd, HK inno.N CorporationDiabetes Mellitus, Type 2
상세
DA5221-B2DA5221-B2Phase 3 ClinicalDong-A ST Co LtdDiabetes Mellitus, Type 2
상세
LID104LID104; LID-104Phase 3 ClinicalEmsDiabetes Mellitus, Type 2
상세
Empagliflozin/Metformin/Sitagliptin (Chong Kun Dang Pharmaceutical)CKD-379Phase 3 ClinicalChong Kun Dang Pharmaceutical CorpDiabetes Mellitus; Diabetes Mellitus, Type 2
상세
TOTUM•63TOTUM-63Phase 3 ClinicalValbiotisDiabetes Mellitus, Type 2
상세
TalabostatVbP; PT-100; BXCL-701Phase 2 ClinicalPoint TherapeuticsAdenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Small Cell; CNS Embryonal Tumor; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Liver Neoplasms; Lung Neoplasms; Melanoma; Myelodysplastic Syndromes; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Neuroendocrine Tumors; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Sarcoma; Skin Neoplasms; Solid tumours
상세
TQ-F3083TQ-F3083; CT-383Phase 2 ClinicalBeijing Centaurus Biopharma Co Ltd, Jiangsu Chia Tai-Tianqing Pharmaceutical Co LtdDiabetes Mellitus; Diabetes Mellitus, Type 2
상세
BegelomabSAND-26; BT 5/9Phase 2 ClinicalAdienneDermatomyositis; Graft vs Host Disease
상세
SingletineDC-291407; DC-407; DC291407Phase 2 ClinicalCisen Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of SciencesDiabetes Mellitus, Type 2; Fatty Liver
상세
GCP-002EP-HMRGPhase 2 ClinicalGoryo Chemical IncEsophageal Neoplasms
상세
Metformin/Dapagliflozin/SitagliptinGMRx4Phase 2 ClinicalGeorge Medicines PTY Ltd, George Medicines UK LtdDiabetes Mellitus, Type 2
상세
Bogliptin maleateHL012MAPhase 2 ClinicalEast China University Of Science And Technology, Shandong Baiji Dichang Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of SciencesDiabetes Mellitus, Type 2
상세
CKD-393CKD-393Phase 1 ClinicalChong Kun Dang Pharmaceutical CorpDiabetes Mellitus, Type 2
상세
Augliptin HydrochloridePhase 1 ClinicalNanjing Changao Pharmaceutical Science And Technologyco Ltd, Shanghai Sun-Sail Pharmaceutical Science & Technology Co LtdDiabetes Mellitus, Type 2
상세
Evogliptin TartrateLY-05007Phase 1 ClinicalDong-A Pharmaceutical Co LtdDiabetes Mellitus, Type 2
상세
Sitagliptin/TelmisartanHDDO-16091 + HDDO-16092; HOB-077; HDDO-1609Phase 1 ClinicalHyundai Pharmaceutical Co LtdDiabetes Mellitus; Hypertension
상세
TSL-0319TSL-0319Phase 1 ClinicalJiangsu Tasly Diyi Pharmaceutical Co LtdDiabetes Mellitus, Type 2
상세
Prusogliptin/Dapagliflozin/MetforminPhase 1 ClinicalCspc Ouyi Pharmaceutical Co LtdDiabetes Mellitus, Type 2
상세
Vildagliptin and Metformin Hydrochloride Extended-Release Tablets(24h)(Taizhou Overseas Pharma)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co LtdDiabetes Mellitus, Type 2
상세
Vildagliptin and Metformin Hydrochloride Extended-Release Tablets(Taizhou Overseas Pharma)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co LtdDiabetes Mellitus, Type 2
상세
Alogliptin and Metformin Hydrochloride Sustained-release Tablets(Taizhou Overseas Pharma)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co LtdDiabetes Mellitus, Type 2
상세
CTL-02CTL-02; CTL02Phase 1 ClinicalCelltrion Inc
상세
Vildagliptin Sustained-release Tablets(Taizhou Overseas Pharma)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co LtdDiabetes Mellitus, Type 2
상세
AJU-A53AJU-A53Phase 1 ClinicalAju Pharm Co LtdDiabetes Mellitus, Type 2
상세
CKD-393(2)CKD-393(2)Phase 1 ClinicalChong Kun Dang Pharmaceutical CorpDiabetes Mellitus, Type 2
상세
ZHB-015ZHB-015; ZHB015; ZHB-C003Phase 1 ClinicalZonhon Biopharma Institute IncSolid tumours
상세
CMR-316CMR316; CMR-316Phase 1 ClinicalThe Calibr-Skaggs Institute for Innovative MedicinesIdiopathic Pulmonary Fibrosis; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome, Adult
상세
Vildagliptin/Empagliflozin/Metformin HydrochloridePhase 1 ClinicalTaizhou Overseas Pharmaceuticals Co LtdDiabetes Mellitus; Diabetes Mellitus, Type 2
상세
CGT-2201CGT-2201Phase 1 ClinicalCgenetech(Suzhou China) Co LtdDiabetes Mellitus; Diabetes Mellitus, Type 2
상세
Empagliflozin/Metformin/Sitagliptin (Overseas Pharmaceuticals)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co LtdDiabetes Mellitus, Type 2
상세
THDBH-100THDBH100; THDBH101Phase 1 ClinicalWuxi Apptec(Shanghai) Co LtdDiabetes Mellitus, Type 2
상세
WXSHC-071WXSHC-071Phase 1 ClinicalDongbao Zixing (Hangzhou) Biological Medicine Co LtdDiabetes Mellitus, Type 2
상세
REC-04ClinicalRecardio IncCardiovascular Diseases
상세
DASH inhibitor (Bach)ClinicalBach Biosciences LLCNeoplasms
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Gemigliptin L-tartrate SesquihydrateLC-150444; LC-15-0444ApprovedLg Chemical LtdGemiglo, ZemigloSouth KoreaDiabetes Mellitus, Type 2Lg Chemical Ltd2012-06-27Diabetes Mellitus, Type 2; Fasting; Hepatic Insufficiency
상세
Gemigliptin L-tartrate Sesquihydrate/Metformin HydrochlorideApprovedLg Chemical LtdZemiMet SRSouth KoreaDiabetes Mellitus, Type 2Lg Chemical Ltd2015-01-01Diabetes Mellitus, Type 2
상세
Teneligliptin Hydrobromide Hydrate/Metformin HydrochlorideApprovedHandok IncTenelia M SRSouth KoreaDiabetes Mellitus, Type 2Handok Inc2015-11-03Diabetes Mellitus, Type 2
상세
EvogliptinDA-1229; RNV-1001ApprovedDong-A Pharmaceutical Co LtdSugarnon, Evodine, Suganon, SUGANONSouth KoreaDiabetes Mellitus, Type 2Dong-A Pharmaceutical Co Ltd2015-10-02Aortic valve diseases; Diabetes Mellitus, Type 2; Liver Dysfunction; Renal Insufficiency
상세
Saxagliptin HydrateBMS-477118; BMS-477118-11; OPC-262ApprovedBristol-Myers Squibb Company安立泽, OnglyzaEUDiabetes Mellitus, Type 2Astrazeneca Ab2009-07-31Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hypoglycemia
상세
Teneligliptin Hydrobromide HydrateMP-513ApprovedMitsubishi Tanabe PharmaTenglyn, TeneliaJapanDiabetes Mellitus, Type 2Mitsubishi Tanabe Pharma, Daiichi Sankyo Co Ltd2012-06-29Diabetes Mellitus, Type 2
상세
Retagliptin PhosphateSP-2086 Phosphate; SP 2086ApprovedJiangsu Hengrui Medicine Co Ltd瑞泽唐Mainland ChinaDiabetes Mellitus, Type 2Jiangsu Hengrui Medicine Co Ltd2023-06-27Diabetes Mellitus; Diabetes Mellitus, Type 2; Renal Insufficiency
상세
Sitagliptin Phosphate Monohydrate/Ipragliflozin L-ProlineMK-0431JApprovedAstellas Pharma Inc, Merck & Co IncSujanuJapanDiabetes Mellitus, Type 2null2018-03-23Diabetes Mellitus, Type 2
상세
PrusogliptinDBPR-108ApprovedNational Health Research Institutes, Taiwan Shenlong Co Ltd善泽平Mainland ChinaDiabetes Mellitus, Type 2Cspc Ouyi Pharmaceutical Co Ltd2025-01-08Diabetes Mellitus, Type 2; Hepatic Insufficiency; Renal Insufficiency
상세
LinagliptinBI-1356; BI-1356-BSApprovedBoehringer Ingelheim International Gmbh欧唐宁, Ondero, Trajenta, Trayenta, Trazenta, TradjentaUnited StatesDiabetes Mellitus, Type 2Boehringer Ingelheim International Gmbh2011-05-02Albuminuria; Coronavirus Disease 2019 (COVID-19); Coronavirus Infections; Diabetes Mellitus; Diabetes Mellitus, Type 2; Endocrine System Diseases; Glucose Metabolism Disorders; Hepatic Insufficiency; Hyperglycemia; Hypertension; Inflammation; Metabolic Diseases; Prediabetic State; Renal Insufficiency; Respiratory Tract Diseases; Schizophrenia; Ventricular Dysfunction, Left
상세
Rosuvastatin Calcium/Gemigliptin L-tartrate SesquihydrateApprovedLg Chemical LtdZemiStatinSouth KoreaDiabetes Mellitus, Type 2; DyslipidemiasLg Chemical Ltd2017-07-31Diabetes Mellitus, Type 2; Dyslipidemias
상세
Alogliptin BenzoateSYR-322; TAK-322ApprovedTakeda Pharmaceutical Co LtdNesina, 尼欣那, VipidiaJapanDiabetes Mellitus, Type 2Takeda Pharmaceutical Co Ltd2010-04-06Acute Coronary Syndrome; Diabetes Mellitus; Diabetes Mellitus, Type 2
상세
Empagliflozin/Linagliptin/MetforminApprovedBoehringer Ingelheim International Gmbh, Eli Lilly And CompanyTrijardy XRUnited StatesDiabetes Mellitus, Type 2Boehringer Ingelheim International Gmbh2020-01-27Diabetes Mellitus, Type 2
상세
Sitagliptin Phosphate/Metformin HydrochlorideApprovedMerck & Co IncVelmetia, Janumet, 捷诺达United StatesDiabetes Mellitus, Type 2Merck & Co Inc2007-03-30Diabetes Mellitus, Type 2
상세
Teneligliptin Hydrobromide Hydrate/Canagliflozin HemihydrateApprovedDaiichi Sankyo Co Ltd, Mitsubishi Tanabe Pharma CorpCanaliaJapanDiabetes Mellitus, Type 2Daiichi Sankyo Co Ltd, Mitsubishi Tanabe Pharma2017-07-03Diabetes Mellitus, Type 2
상세
Anagliptin/Metformin HydrochlorideSK-1501ApprovedSanwa Kagaku Kenkyusho Co Ltd, SuzukenMetoanaJapanDiabetes Mellitus, Type 2Sanwa Kagaku Kenkyusho Co Ltd2018-09-21Diabetes Mellitus, Type 2
상세
Vildagliptin/Metformin HydrochlorideLMF-237ApprovedNovartis Pharma Ag宜合瑞, Eucreas, EquMet, Zomarist, Icandra, GalvusmetEUDiabetes Mellitus, Type 2Novartis Europharm Ltd2007-11-14Diabetes Mellitus, Type 2
상세
Sentagliptin PhosphateCGT-8012ApprovedCgenetech(Suzhou China) Co Ltd盛捷维Mainland ChinaDiabetes Mellitus, Type 2Cgenetech(Suzhou China) Co Ltd2024-12-01Diabetes Mellitus, Type 2
상세
Alogliptin Benzoate/Metformin HydrochlorideCT-L01; CT-L-01ApprovedTakeda Pharmaceutical Co LtdVipdomet, Inisync, KazanoUnited StatesDiabetes Mellitus, Type 2Takeda Pharmaceuticals USA Inc2013-01-25Diabetes Mellitus, Type 2
상세
Fultagliptin BenzoateFCN-005; SAL067; SAL-067Approved信立汀Mainland ChinaDiabetes Mellitus, Type 2Shenzhen Salubris Pharmaceuticals Co Ltd2024-06-28Diabetes Mellitus, Type 2; Renal Insufficiency
상세
CofrogliptinHSK7653; HSK-7653ApprovedLiaoning Haisco Pharmaceutical Co Ltd, Sichuan Haisco Pharmaceutical Co Ltd倍长平Mainland ChinaDiabetes Mellitus, Type 2Haisco Pharmaceutical Group Co Ltd2024-06-18Diabetes Mellitus, Type 2; Glucose Intolerance; Renal Insufficiency
상세
AnagliptinSK-0403; CWP-0403ApprovedSanwa Kagaku Kenkyusho Co LtdSuiny, BeskoaJapanDiabetes Mellitus, Type 2null2012-09-28Diabetes Mellitus, Type 2
상세
Dapagliflozin Propanediol Monohydrate/Saxagliptin HydrochlorideApprovedAstrazeneca PlcQternEUDiabetes Mellitus, Type 2Astrazeneca Ab2016-07-15Diabetes Mellitus, Type 2
상세
Alogliptin Benzoate/Pioglitazone HydrochlorideSYR-322-4833 BLApprovedTakeda Pharmaceutical Co LtdNesinaact, Oseni, Liovel, IncresyncJapanDiabetes Mellitus, Type 2Takeda Pharmaceutical Co Ltd2011-07-01Diabetes Mellitus, Type 2
상세
Sitagliptin Phosphate MonohydrateONO-5435A; ONO-5435; MK-0431; MK-431; L-000224715ApprovedMerck Sharp & Dohme CorpRistaben, Xelevia, Tesavel, Glactiv, 捷诺维, Januvia, DIABIT-IS XUnited StatesDiabetes Mellitus, Type 2Merck & Co Inc2006-10-16Atherosclerosis; Carcinoma, Hepatocellular; Cardiovascular Diseases; Coronavirus Disease 2019 (COVID-19); Cystic Fibrosis; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Gastroparesis; Glucose Intolerance; Graft vs Host Disease; Heart Failure; Hepatic Insufficiency; Hepatitis C; HIV Infections; Hyperlipidemias; Inflammation; Insulin Resistance; Kidney Failure, Chronic; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Metabolic Dysfunction-Associated Steatotic Liver Disease; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prediabetic State; Psoriasis; Renal Insufficiency; Renal Insufficiency, Chronic
상세
Trelagliptin SuccinateTAK-472; SYR-472; SYR-111472; SYR-111472 succinateApprovedTakeda Pharmaceutical Co LtdZafatekJapanDiabetes Mellitus, Type 2Takeda Pharmaceutical Co Ltd2015-03-26Diabetes Mellitus; Diabetes Mellitus, Type 2
상세
Evogliptin Tartrate/Metformin HydrochlorideDA-1229_01ApprovedDong-A Pharmaceutical Co LtdSugamet XRSouth KoreaDiabetes Mellitus, Type 2Dong-A Pharmaceutical Co Ltd2015-12-01Diabetes Mellitus, Type 2
상세
Sitagliptin/ErtugliflozinApprovedPfizer IncSteglujanUnited StatesDiabetes Mellitus, Type 2Merck & Co Inc2017-12-19Diabetes Mellitus, Type 2
상세
Retagliptin Phosphate/Metformin HydrochlorideHRX-0701; HRX0701ApprovedJiangsu Hengrui Medicine Co Ltd瑞霖唐Mainland ChinaDiabetes Mellitus, Type 2Shandong Shengdi Pharmaceutical Co Ltd2025-05-20Diabetes Mellitus, Type 2
상세
Sitagliptin/Metformin Hydrochloride (Zydus Lifesciences)ApprovedZydus Lifesciences LtdZituvimet, ZITUVIMETUnited StatesDiabetes Mellitus, Type 2Zydus Lifesciences Ltd2023-11-03Diabetes Mellitus, Type 2
상세
OmarigliptinMK-3102ApprovedMerck & Co IncMarizevJapanDiabetes Mellitus, Type 2Merck Sharp & Dohme Corp2015-09-28Diabetes Mellitus; Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic
상세
Henagliflozin/metformin/retagliptin (Shandong Shengdi)HR20031; HR-20031ApprovedShandong Shengdi Pharmaceutical Co Ltd瑞乐唐Mainland ChinaDiabetes Mellitus; Diabetes Mellitus, Type 2Shandong Shengdi Pharmaceutical Co Ltd2025-10-21Diabetes Mellitus; Diabetes Mellitus, Type 2
상세
Teneligliptin/PioglitazoneApprovedGlenmark Pharmaceuticals LtdZita Plus PioIndiaDiabetes Mellitus, Type 2Glenmark Pharmaceuticals Ltd2022-04-25Diabetes Mellitus, Type 2
상세
Dapagliflozin Propanediol Hydrate/Sitagliptin Phosphate HydrateSID-1903; DW-6012ApprovedDong Wha Pharm Co LtdSidapviaSouth KoreaDiabetes Mellitus, Type 2Dong Wha Pharm Co Ltd2023-06-30Diabetes Mellitus, Type 2; Myocardial Infarction; ST Elevation Myocardial Infarction
상세
Metformin Hydrochloride/Sitagliptin HydrochlorideApprovedSandoz BvEUSandoz Bv2019-12-10
상세
Sitagliptin TartrateApprovedHeumann Pharma GmbH & Co Generica KGSitagliptin Heumann 25 mg FilmtablettenEUHeumann Pharma GmbH & Co Generica KG2020-12-14Diabetes Mellitus, Type 1; Diabetic Nephropathies; Metabolic Dysfunction-Associated Steatotic Liver Disease; Parkinson Disease
상세
Sitagliptin HydrochlorideApprovedLaboratorios Alter SaSpainDiabetes Mellitus, Type 2Laboratorios Alter Sa2019-03-06Diabetes Mellitus, Type 2; Polycystic Ovary Syndrome
상세
Gemigliptin/DapagliflozinApprovedLg Chemical LtdZemidapaSouth KoreaDiabetes Mellitus, Type 2Lg Chemical Ltd2022-06-21Diabetes Mellitus, Type 2
상세
Linagliptin/Metformin HydrochlorideGC2129A; GC-2129-A; DW6013ApprovedBoehringer Ingelheim International GmbhJentadueto Xr, Trajenta Duo, Jentadueto, 欧双宁United StatesDiabetes Mellitus, Type 2Boehringer Ingelheim International Gmbh2012-01-30Diabetes Mellitus, Type 2
상세
Linagliptin/EmpagliflozinBI 1356/BI 10773; BI 10773/linagliptin; BI 1356/empagliflozin; Empagliflozin/BI 1356; Linagliptin/BI 10773; BI 10773/BI 1356ApprovedC.H. Boehringer Sohn Ag & Co. KgTradiance, Glyxambi, EsgliteoUnited StatesDiabetes Mellitus, Type 2Boehringer Ingelheim International Gmbh2015-01-30Cardiovascular Diseases; Diabetes Mellitus, Type 2
상세
VildagliptinLAF-237; DSP-7238; LAF-237A; NVP-LAF-237ApprovedNovartis Pharma Ag佳维乐, Equa, Jalra, Galvus, Gliptus, XiliarxEUDiabetes Mellitus, Type 2Novartis Europharm Ltd2007-09-25Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dyslipidemias; Insulin Resistance; Prediabetic State; Renal Insufficiency; Schizophrenia
상세
Saxagliptin Hydrochloride/Metformin HydrochlorideApprovedAstrazeneca Plc安立格, Kombiglyze Xr, KomboglyzeEUDiabetes Mellitus, Type 2Astrazeneca Ab2010-11-05Diabetes Mellitus, Type 2
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호